An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sabra Health Care REIT, Inc. Announces Pricing of Public Offering of $800.0 Million of 3.200% Senior Notes due 2031 by Its Subsidiary Sabra Health Care Limited Partnership
Sabra Health Care REIT, Inc. (SBRA) announced its subsidiary, Sabra Health Care Limited Partnership, has priced $800 million in 3.200% senior notes due 2031. The offering, under an SEC registration statement, is expected to close on September 30, 2021. Proceeds will be used to redeem existing 4.80% senior notes due 2024 and repay $345 million in term loans maturing on September 9, 2023, alongside funding future investments and general corporate purposes. The offering is managed by Wells Fargo Securities, BofA Securities, Credit Agricole, and J.P. Morgan.
Positive
Issuance of $800 million in senior notes can lower interest obligations.
Proceeds designated to repay high-interest 4.80% senior notes and term loans improve financial stability.
Plans for future investments could enhance growth opportunities.
Negative
Existing debt repayments may indicate potential liquidity challenges.
Issuing new debt could lead to shareholder dilution.
IRVINE, Calif.--(BUSINESS WIRE)--
Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that its subsidiary, Sabra Health Care Limited Partnership (the “Issuer”), has priced and entered into an agreement to issue and sell, subject to certain conditions, $800.0 million aggregate principal amount of 3.200% senior notes due 2031 (the “Notes”) pursuant to an effective registration statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended, on December 11, 2019. The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Sabra. Sabra expects to close the offering on September 30, 2021, subject to the satisfaction of customary closing conditions and the delivery by the Issuer prior to closing of an irrevocable notice of redemption for all of its outstanding 4.80% senior notes due 2024 (the “2024 Notes”), which the Issuer intends to do.
Sabra intends to use a portion of the net proceeds from the offering of the Notes to (i) redeem all of the 2024 Notes and (ii) repay approximately $345.0 million of its U.S. dollar term loans maturing on September 9, 2023, and the remaining net proceeds to fund future investments or for general corporate purposes. Prior to these uses, Sabra may temporarily use net proceeds designated for such purposes to repay borrowings outstanding on its unsecured revolving credit facility and/or invest in interest-bearing accounts and short-term, interest-bearing securities.
In connection with the offering, Wells Fargo Securities, LLC, BofA Securities, Inc., Credit Agricole Securities (USA) Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers. You may obtain a copy of the prospectus supplement and the related prospectus for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, you may request a copy of the prospectus supplement and the related prospectus by calling Wells Fargo Securities, LLC toll-free at 1-800-645-3751, BofA Securities, Inc. toll-free at 1-800-294-1322, Credit Agricole Securities (USA) Inc. toll-free at 1-866-807-6030, or J.P. Morgan Securities LLC collect at 1-212-834-4533.
Any offer of the Notes will be made solely by means of the prospectus included in the registration statement and the prospectus supplement relating to the offering.
Forward-Looking Statements
Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Sabra with the SEC and include Sabra’s ability to successfully complete the offering on satisfactory terms and conditions or at all, and the intended use of proceeds, each of which may be impacted by, among other things, the ongoing COVID-19 pandemic, changes in general economic conditions and volatility in financial and credit markets, as well as other risks and uncertainties, including those detailed from time to time in Sabra’s SEC filings. More information on factors that could affect Sabra’s business and financial results are included in Sabra’s public filings made with the SEC, including Sabra’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Sabra’s control. Sabra cautions investors that any forward-looking statements made by Sabra are not guarantees of future performance and are only made as of the date of this release. Sabra disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.
What is the purpose of the $800 million senior notes offering by Sabra Health Care REIT?
The offering will be used to redeem existing 4.80% senior notes due 2024 and repay $345 million in maturing term loans, contributing to improved financial stability.
When is the expected closing date of the senior notes offering for SBRA?
The expected closing date for the offering is September 30, 2021.
What are the risks associated with Sabra's new senior notes offering?
Risks include potential liquidity challenges due to debt repayments and the possibility of shareholder dilution from issuing new debt.
Who are the underwriters for the senior notes offering by Sabra Health Care REIT?
Wells Fargo Securities, BofA Securities, Credit Agricole, and J.P. Morgan are acting as joint book-running managers for the offering.
